109. Allers, K., G. Hutter, J. Hofmann, C. Loddenkemper, K. Rieger, E. Thiel, and T. Schneider. “Evidence for the Cure of HIV Infection by CCR5 Delta32/ Delta32 Stem Cell Transplantation.” Blood 117 (2011): 2791–99.

110. Liu, R., W. A. Paxton, S. Choe, D. Ceradini, S. R. Martin, R. Horuk, M. E. MacDonald, H. Stuhlmann, R. A. Koup, and N. R. Landau. “Homozygous Defect in HIV– 1 Coreceptor Accounts for Resistance of Some Multiply– Exposed Individuals to HIV– 1 Infection.” Cell 86 (1996): 367–77.

1. Besnoit, C. “La tremblante ou nevrite peripherique enzootique du mouton.” Revue Vétérinaire Toulouse 24 (1899): 265–77.

2. Cuillé, J., and P. L. Chelle. “Pathologie animal– la maladie dite tremblante du mouton est– elle inoculable.” Comptes Rendu des Seances de l’Académie de Sciences Paris 203 (1936): 1552–54.

3. Cuillé, J., and P. L. Chelle. “Investigations of Scrapie in Sheep.” Veterinary Medicine 34 (1939): 417–18.

4. Gajdusek, D. C., and V. Zigas. “Degenerative Disease of the Central Nervous System in New Guinea. The Endemic Occurrence of ‘Kuru’ in the Native Population.” New England Journal of Medicine 257 (1957): 974–78.

5. Gajdusek, D. C. “Kuru.” Transactions of the Royal Society of Tropical Medicine and Hygiene 57 (1963): 151–69.

6. Gajdusek, D. C. “Kuru in New Guinea.” In Slow, Latent, and Temperate Virus Infections. NINDB Monograph No. 2, 3–12. Bethesda, MD: US Department of Health, Education, and Welfare, 1965.

7. Hadlow, W. J. “Scrapie and Kuru.” Lancet 274 (1959): 289–290.

8. Chesebro, B. “Prion Protein and the Transmissible Spongiform Encephalopathy Diseases.” Neuron 24 (1999): 503–6.

9. Gajdusek, D. C. “Infectious Amyloids: Subacute Spongiform Encephalopathies as Transmissible Cerebral Amyloidosis.” In Fields Virology, edited by B. N. Fields, 2851–2900. Philadelphia: Lippincott– Raven, 1996.

10. Prusiner, S. B. “Prions.” In Fields Virology, 5th ed., edited by D. Knipe and P. Howley, 3059–91, Philadelphia: Lippincott Williams & Wilkins, 2007.

11. Prusiner, S. B. Prion Biology and Diseases. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press, 1999.

12. Donnelly, C. A., N. M. Ferguson, A. C. Ghani, and R. M. Anderson. “Implications of BSE Infection Screening Data for the Scale of the British BSE Epidemic and Current European Infection Levels.” Proceedings Biological Sciences 269 (2002): 2179–90.

13. Anderson, R. M., C. A. Donnelly, N. M. Ferguson, M. E. J. Woolhouse, C. J. Watt, H. J. Udy, S. MaWhinney, et al. “Transmission Dynamics and Epidemiology of BSE in British Cattle.” Nature 382 (1996): 779–88.

14. Butler, D. “BSE Researchers Bemoan ‘Ministry Secrecy.’” Nature 383 (1996): 467–68.

15. Butler, D. “CJD Variant Stirs Debate on Release of Data.” Nature 384 (1996): 658.

16. Sawcer, S. J., G. M. Yuill, T. F. G. Esmonde, P. Estibeiro, J. W. Ironside, J. E. Bell, and R. G. Will. “Creutzfeldt– Jakob Disease in an Individual Occupationally Exposed to BSE.” Lancet 341 (1993): 642.

17. Davies, P. T. G., S. Jahfar, I. T. Ferguson, and O. Windl. “Creutzfeldt– Jakob Disease in Individuals Occupationally Exposed to BSE.” Lancet 342 (1993): 680.

18. Smith, P. E. M., M. Zeidler, J. W. Ironside, P. Estibeiro, and T. H. Moss. “Creutzfeldt– Jakob Disease in a Dairy Farmer.” Lancet 346 (1995): 898.

19. Britton, T. C., S. Al– Sarraj, C. Shaw, T. Campbell, and J. Collinge. “Sporadic Creutzfeldt– Jakob Disease in a 16– Year– Old in the UK.” Lancet 346 (1995): 1155.

20. Bateman, D., D. Hilton, S. Love, M. Zeidler, J. Beck, and J. Collinge. “Sporadic Creutzfeldt– Jakob Disease in a 18– Year– Old in the UK.” Lancet 346 (1995): 1155–56.

21. Will, R. G., J. W. Ironside, M. Zeidler, S. N. Cousens, K. Estibeiro, A. Alperovitch, S. Poser, M. Pocchiari, M. Hofman, and P. G. Smith. “A New Variant of Creutzfeldt– Jakob Disease in the UK.” Lancet 347 (1996): 921–25.

22. Masood, E. “‘Mad Cow’ Scare Threatens Political Link Between Food and Agriculture.” Nature 380 (1996): 273–74.

23. “Lessons from BSE for Public Confidence.” Editorial, Nature 380 (1996): 271.

24. Butler, D. “Slow Release of Data Adds to BSE Confusion.” Nature 380 (1996): 370.

25. O’Brien, C. “Mad Cow Disease. Scant Data Cause Widespread Concern.” Science 271 (1996): 1798.

26. Douet, J. Y., C. Lacroux, N. Aron, M. W. Head, S. Lugan, C. Tillier, A. Huor, et al. “Distribution and Quantitative Estimates of Variant Creutzfeldt– Jakob Disease Prions in Tissues of Clinical and Asymptomatic Patients.” Emerging Infectious Diseases 23 (2017): 946–56.

27. Gill, O. N., Y. Spencer, A. Richard– Loendt, C. Kelly, R. Dabaghian, L. Boyes, J. Linehan, et al. “Prevalent Abnormal Prion Protein in Human Appendixes after Bovine Spongiform Encephalopathy Epizootic: Large Scale Survey.” British Medical Journal 347 (2013): f5675.

28. Moda, F., P. Gambetti, S. Notari, L. Concha– Marambio, M. Catania, K.– W. Park, E. Maderna, et al. “Prions in the Urine of Patients with Variant Creutzfeldt– Jakob Disease.” New England Journal of Medicine 371 (2014): 530–39.

29. Lacroux, C., E. Comoy, M. Moudjou, A. Perret– Liaudet, S. Lugan, C. Litaise, H. Simmons, et al. “Preclinical Detection of Variant CJD and BSE Prions in Blood.” PLoS Pathogens 10 (2014): e1004202.

30. Peden, A., L. McCardle, M. W. Head, S. Love, H. J. T. Ward, S. N. Cousens, D. M. Keeling, C. M. Millar, F. G. H. Hill, and J. W. Ironside. “Variant CJD Infection in the Spleen of a Neurologically Asymptomatic UK Adult Patient with Haemophilia.” Haemophilia 16 (2010): 296–304.

31. Llewelyn, C. A., P. E. Hewitt, R. S. Knight, K. Amar, S. Cousens, J. Mackenzie, and R. G. Will. “Possible Transmission of Variant Creutzfeldt– Jakob Disease by Blood Transfusion.” Lancet 363 (2004): 417–21.

32. Lefrere, J. J., and P. Hewitt. “From Mad Cows to Sensible Blood Transfusion: The Risk of Prion Transmission by Labile Blood Components in the United Kingdom and in France.” Transfusion 49 (2009): 797–812.

33. Saborio, G. P., B. Permanne, and C. Soto. “Sensitive Detection of Pathological Prion Protein by Cyclic Amplification of Protein Misfolding.” Nature 411 (2001): 810–13.

34. Peden, A. H., M. W. Head, D. L. Ritchie, J. E. Bell, and J. W. Ironside. “Preclinical vCJD after Blood Transfusion in a PRNP Codon 129 Heterozygous Patient.” Lancet 364 (2004): 527–29.